×
About 1,103 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  301 results

Automated Insulin Dosing Systems: Advances After a Century of Insulin.
https://doi.org/10.1111/dme.14695
Diabetic Medicine : a Journal of the British Diabetic Ass... Thabit H, Lal R et. al.

Sep 22nd, 2021 - The daily complexities of insulin therapy and glucose variability in type 1 diabetes still pose significant challenges, despite advancements in modern insulin analogues. Minimising hypoglycaemia and optimising time spent within target glucose rang...

Novel continuous glucose monitoring metrics and LGA risk; an exploratory retrospective ...
https://doi.org/10.1089/dia.2021.0194
Diabetes Technology & Therapeutics; Sibiak R, Gutaj P et. al.

Sep 16th, 2021 - Continuous glucose monitoring (CGM) improves pregnancy outcomes in patients with type 1 diabetes (T1D). We aimed to assess the between-group differences in HbA1c and the incidence of large-for-gestational-age (LGA) neonates in CGM and glucometers ...

Skin involvement in paediatric patients with type 1 diabetes.
https://doi.org/10.2174/1573399817666210903153837
Current Diabetes Reviews; Passanisi S, Salzano G et. al.

Sep 4th, 2021 - Skin involvement is an overlooked aspect in the management of paediatric patients with type 1 diabetes. A comprehensive search of published literature using the PubMed database was carried out using the following key terms: "children", "pediatric/...

An algorithm mimicking pancreas pulsatile behavior improves artificial pancreas perform...
https://doi.org/10.1177/03913988211027176
The International Journal of Artificial Organs; Cocha G, Tedesco V et. al.

Aug 6th, 2021 - Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-forward boluses often induces an over-response leading to hypoglycemia due to the increase of blood insulin concentration sustained in time. The objective of this...

Predictors of the effectiveness of insulin pumps in patients with type 1 diabetes melli...
https://doi.org/10.1007/s12020-021-02837-4 10.1515/JPEM.2001.14.S1.619 10.1038/nrdp.2017.16 10.1016/S0140-6736(13)60591-7 10.1080/0886022X.2016.1193872 10.2337/db11-0082 10.1001/archinternmed.2009.193 10.2337/diacare.13.4.427 10.1016/s0002-9149(99)80683-3 10.1590/S0004-27302008000200010 10.1016/S0168-8227(06)70009-2 10.2337/diacare.27.2007.S106 10.2337/dc16-1728 10.3390/jcm5010005 10.1056/NEJMct1113948 10.1038/s41574-018-0044-y 10.1001/jama.2017.13994 10.1136/bmjopen-2019-033059 10.2337/diacare.27.7.1554 10.1089/dia.2014.1503 10.1089/dia.2009.0182 10.1089/dia.2009.0161 10.1111/dme.12792 10.1007/s00592-015-0784-2 10.1016/j.jdiacomp.2012.03.016 10.3349/ymj.2018.59.1.92 10.4158/EP-2019-0351 10.1007/s005920200028 10.1111/j.1464-5491.2005.01618.x 10.1111/j.1399-543X.2006.00169.x 10.4239/wjd.v6.i2.352 10.1038/s41598-019-45369-8 10.2310/JIM.0b013e318197ec8b 10.1007/s00125-006-0269-5 10.1186/s40360-019-0314-x 10.1016/j.diabres.2015.10.022 10.1016/j.diabres.2004.11.005 10.1016/j.diabres.2020.108026 10.1111/jdi.12320 10.1111/j.1464-5491.2010.03068.x 10.1111/j.1464-5491.2010.03068.x 10.1016/j.jpeds.2009.01.063 10.1111/j.1399-543X.2006.00145.x 10.1001/jama.1984.03350230025026 10.2337/dc19-0630 10.1002/dmrr.482
Endocrine Neves JC, Neves JS et. al.

Aug 3rd, 2021 - Insulin pump therapy has become the preferential treatment for type 1 diabetes (T1D) as it mimics the physiological secretion of insulin better than multiple daily injections. However, not all patients improve with insulin pump therapy. This study...

see more →

Guidelines  2 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Ass... Choudhary P, Campbell F et. al.

Feb 19th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American Col... Grunberger G, Handelsman Y et. al.

Mar 17th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

see more →

Drugs  1 results see all →

News  137 results

'A Better Picture': First AACE Guidelines on Diabetes Technology
https://www.medscape.com/viewarticle/952127

May 31st, 2021 - The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with diabetes. The guidelines cover use of continuous glucose monitorin...

Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes
https://www.medscape.com/viewarticle/947742

Mar 19th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

2019 Medical Device Recalls | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/2019-medical-device-recalls

The list below contains recalls that were issued in 2019. 2019 Medical Device Recalls Device Name Date LivaNova Recalls VNS Therapy SenTiva Generator Due to Reset Error 12/20/19 Smiths Medical ASD, Inc. Recalls Medfusion® 4000 Syringe Pumps Due to...

Huge Variations in Access Holding Back T1D Tech Adoption
https://www.medscape.com/viewarticle/941101

Nov 17th, 2020 - Increased adoption of the latest technologies to manage type 1 diabetes is being held back by a lack of knowledge of the benefits among clinicians in certain areas of England and Wales, leading to wide variations in access, say UK experts. They ar...

Proposed Medicare Rule Would Expand CGM Coverage
https://www.medscape.com/viewarticle/940743

Nov 10th, 2020 - A new proposed rule from the Centers for Medicare & Medicaid Services (CMS) would expand coverage for continuous glucose monitors (CGMs) under Medicare to include devices that aren't approved for making treatment decisions. If accepted, the propos...

see more →